Daré Bioscience, Inc.
DARE
$2.04
-$0.04-1.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.60M | -1.68M | -4.05M | -3.60M | -7.20M |
| Total Depreciation and Amortization | 634.30K | 189.60K | 42.30K | 45.90K | 45.50K |
| Total Amortization of Deferred Charges | 11.60K | 38.70K | 21.90K | 21.90K | 21.90K |
| Total Other Non-Cash Items | 2.53M | 2.65M | 3.59M | 2.36M | 2.41M |
| Change in Net Operating Assets | 3.84M | 5.54M | 5.79M | -6.84M | -5.33M |
| Cash from Operations | -11.59M | 6.74M | 5.39M | -8.01M | -10.06M |
| Capital Expenditure | -284.40K | -723.00K | -573.00K | -617.50K | -921.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -284.40K | -723.00K | -573.00K | -617.50K | -921.90K |
| Total Debt Issued | 561.70K | 561.70K | 561.70K | 561.70K | 601.20K |
| Total Debt Repaid | -1.02M | -566.00K | -579.20K | -592.40K | -601.20K |
| Issuance of Common Stock | 966.70K | 674.70K | 453.60K | 1.18M | 9.29M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -700.00 | -4.00K | -2.20K | 4.72M | 4.72M |
| Cash from Financing | 507.20K | 666.40K | 433.80K | 5.88M | 14.02M |
| Foreign Exchange rate Adjustments | -17.30K | -15.60K | -67.90K | 56.90K | 19.00K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | -11.38M | 6.66M | 5.19M | -2.70M | 3.05M |